Flosonics Medical accepted into the Ontario Bioscience Innovation Organization’s Capital Access Advisory Program.  “CAAP is a focused opportunity for early stage bioscience companies to gain access to investors, advisors and mentorship. CAAP allows companies to rapidly execute on their strategic business goals, accelerate business development and attract necessary financing to fuel company growth,”